Big Data Analytics for Genomic Medicine
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Genomic medicine attempts to build individualized strategies for diagnostic or therapeutic decision-making by utilizing patients’ genomic information. Big Data analytics uncovers hidden patterns, unknown correlations, and other insights through examining large-scale various data sets. While integration and manipulation of diverse genomic data and comprehensive electronic health records (EHRs) on a Big Data infrastructure exhibit challenges, they also provide a feasible opportunity to develop an efficient and effective approach to identify clinically actionable genetic variants for individualized diagnosis and therapy. In this paper, we review the challenges of manipulating large-scale next-generation sequencing (NGS) data and diverse clinical data derived from the EHRs for genomic medicine. We introduce possible solutions for different challenges in manipulating, managing, and analyzing genomic and clinical data to implement genomic medicine. Additionally, we also present a practical Big Data toolset for identifying clinically actionable genetic variants using high-throughput NGS data and EHRs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.30 · Cited by 32,594
A global reference for human genetic variation
The 1000 Genomes Project Consortium, authors, C., Auton, A., Abecasis, G. R., Steering committee, Altshuler, D. M., Durbin, R. M., Abecasis, G. R., Bentley, D. R., Chakravarti, A., et al. (2015) · Nature · doi:10.1038/nature15393 · Cited by 18,247 · cited 1×
“It also discovers variants in conserved regions and identifies variants present in dbSNP [69], the 1000 Genomes Project [70], the NHLBI EPS6500 project [71], and the ExAC [72].”
BackgroundA method and server for predicting damaging missense mutations.
Adzhubei, I. A., Schmidt, S., Peshkin, L., Ramensky, V. E., Gerasimova, A., Bork, P., Kondrashov, A. S., & Sunyaev, S. R. (2010) · Nature Methods · doi:10.1038/nmeth0410-248 · Cited by 13,194 · cited 2×
“Tools such as POLYPHEN-2 [66], VEP [97], Mutation Assessor [98], and SIFT [99] can be used to predict variant effects.”
MethodCingolani, P., Platts, A., Wang, L. L., Coon, M., Nguyen, T., Wang, L., Land, S. J., Lu, X., & Ruden, D. M. (2012) · Fly · doi:10.4161/fly.19695 · Cited by 11,816
Analysis of protein-coding genetic variation in 60,706 humans
Exome Aggregation Consortium, Lek, M., Karczewski, K. J., Minikel, E. V., Samocha, K. E., Banks, E., Fennell, T., O’Donnell-Luria, A. H., Ware, J. S., Hill, A. J., et al. (2016) · Nature · doi:10.1038/nature19057 · Cited by 9,587
The Ensembl Variant Effect Predictor
McLaren, W., Gil, L., Hunt, S. E., Riat, H. S., Ritchie, G. R. S., Thormann, A., Flicek, P., & Cunningham, F. (2016) · Genome Biology · doi:10.1186/s13059-016-0974-4 · Cited by 8,099 · cited 2×
“Tools such as POLYPHEN-2 [66], VEP [97], Mutation Assessor [98], and SIFT [99] can be used to predict variant effects.”
MethoddbSNP: the NCBI database of genetic variation
Sherry, S. T. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.1.308 · Cited by 7,502
Van der Auwera, G. A., Carneiro, M. O., Hartl, C., Poplin, R., del Angel, G., Levy‐Moonshine, A., Jordan, T., Shakir, K., Roazen, D., Thibault, J., et al. (2013) · Current Protocols in Bioinformatics · doi:10.1002/0471250953.bi1110s43 · Cited by 6,687 · cited 1×
“In addition, it employs a MapReduce infrastructure to accelerate the procedure of processing large amounts of sequence aligned reads in parallel [59,60].”
MethodKumar, P., Henikoff, S., & Ng, P. C. (2009) · Nature Protocols · doi:10.1038/nprot.2009.86 · Cited by 6,521 · cited 1×
“As one of the most widely used annotation programs, ANNOVAR [65] annotates SNVs, INDELs, and CNVs by exploring their functional consequences on genes, conjecturing cytogenetic bands, and reporting biological functions and various functional scores, including PolyPhen-2 score [66], Sorting Intolerant From Tolerant (SIF…”
MethodA New Initiative on Precision Medicine
Collins, F. S., & Varmus, H. (2015) · New England Journal of Medicine · doi:10.1056/nejmp1500523 · Cited by 5,202
Cited by
Privacy-preserving artificial intelligence in healthcare: Techniques and applications
Khalid, N., Qayyum, A., Bilal, M., Al-Fuqaha, A., & Qadir, J. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.106848 · Cited by 581
Concurrence of big data analytics and healthcare: a systematic review
Mehta, N., & Pandit, A. (2018) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2018.03.013 · Cited by 494
Surveillance of antimicrobial resistance in low- and middle-income countries: a scattered picture
Iskandar, K., Molinier, L., Hallit, S., Sartelli, M., Hardcastle, T. C., Haque, M., Lugova, H., Dhingra, S., Sharma, P., Islam, S., et al. (2021) · Antimicrobial Resistance & Infection Control · doi:10.1186/s13756-021-00931-w · Cited by 479
Artificial intelligence (AI) and big data in cancer and precision oncology
Dlamini, Z., Francies, F. Z., Hull, R., & Marima, R. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.08.019 · Cited by 398
Big Data Analytics in Medicine and Healthcare
Ristevski, B., & Chen, M. (2018) · Journal of Integrative Bioinformatics · doi:10.1515/jib-2017-0030 · Cited by 373
Recent Advancements in Emerging Technologies for Healthcare Management Systems: A Survey
Junaid, S. B., Imam, A. A., Balogun, A. O., De Silva, L. C., Surakat, Y. A., Kumar, G., Abdulkarim, M., Shuaibu, A. N., Garba, A., Sahalu, Y., et al. (2022) · Healthcare · doi:10.3390/healthcare10101940 · Cited by 353
Human gene and disease associations for clinical‐genomics and precision medicine research
Ahmed, Z., Zeeshan, S., Mendhe, D., & Dong, X. (2020) · Clinical and Translational Medicine · doi:10.1002/ctm2.28 · Cited by 291
Artificial intelligence aids in development of nanomedicines for cancer management
Tan, P., Chen, X., Zhang, H., Wei, Q., & Luo, K. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.01.005 · Cited by 246
Molla, G., & Bitew, M. (2024) · Biomedicines · doi:10.3390/biomedicines12122750 · Cited by 246
“By facilitating more precise, predictive, and preventive strategies, personalized medicine is expected to enhance patient outcomes and elevate the overall state of public health [77].”
Future cancer research priorities in the USA: a Lancet Oncology Commission
Jaffee, E. M., Dang, C. V., Agus, D. B., Alexander, B. M., Anderson, K. C., Ashworth, A., Barker, A. D., Bastani, R., Bhatia, S., Bluestone, J. A., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30698-8 · Cited by 208
Artificial Intelligence: power for civilisation – and for better healthcare
Horgan, D., Romao, M., Morré, S. A., & Kalra, D. (2019) · Public Health Genomics · doi:10.1159/000504785 · Cited by 86
“Its superior computation ability allows it to analyse data points as diverse as genetic data, DNA sequencing data, profiles, and elec-tronica health records, as well as certain lifestyle data [23].”
Metadata
- Authors
- He, K., Ge, D., & He, M.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2017-02-15
- Volume
- 18
- Issue
- 2
- Pages
- 412
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2588050043
- Cited by
- 178
- References
- 27
- FWCI
- 12.93
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.